The expansion will create 400 jobs dedicated to GLP-1 injectables production across Resilience’s contract manufacturing facilities.

Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies embark on a $750 million investment to increase production of Lilly’s KwikPen injectable device…

Gerresheimer sells Centor and PPP unit to Apax Funds for €1.5B; Resilience and Lilly invest $750M in Ohio manufacturing; Teva books $70M European impairment charge.